GLP-1 receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-02-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual incretin receptor agonist |
| Amino acid count | 39 residues | Includes non-natural residues |
| Approximate mass | 4.8 kDa | Reported values vary slightly by source |
| Fatty acid component | C20 diacid | Supports albumin binding |
| First US approval | 2022 | Glycemic indication, weight management followed |
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
=== Educational goals === John White (2013) investigated the educational goals at public schools in Britain. School-education involves both cognitive and conceptual learning, but also the development social skills and personal development. Ideally, children develop self-confidence, and create purpose for themselves. According to White, in the past schools only focused on knowledge and education but now Britain has moved to a broader direction. White's Every Child Matters initiative seeks to enhance children's well-being across the range of children's services.
In 1959, Adolf Butenandt identified the first intraspecific chemical signal (bombykol) from the silk moth, Bombyx mori, with material obtained by grinding up 500,000 moths. The same year, Karlson and Lüscher proposed the term 'pheromone' to describe this type of signal. Also in 1959, Gottfried S. Fraenkel also published his landmark paper, "The Raison d'être of Secondary Plant Substances", arguing that plant secondary are not metabolic waste products, but actually evolved to protect plants from consumers. Together, these papers marked the beginning of modern chemical ecology. In 1964, Paul R. Ehrlich and Peter H. Raven coauthored a paper proposing their influential theory of escape and radiate coevolution, which suggested that an evolutionary "arms-race" between plants and insects can explain the extreme diversification of plants and insects. The idea that plant metabolites could not only contribute to the survival of individual plants, but could also influence broad macroevolutionary patterns, would turn out to be highly influential. However, Tibor Jermy questioned the view of an evolutionary arms race between plants and their insect herbivores and proposed that the evolution of phytophagous insects followed and follows that of plants without major evolutionary feedback, i.e. without affecting plant evolution. He coined the term sequential evolution to describe plant-insect macroevolutionary patterns, which emphasizes that selection pressure exerted by insect attack on plants is weak or lacking.
Meanwhile, sequencing of human cDNA sequences called expressed sequence tags began in Craig Venter's lab, an attempt to capture the coding fraction of the human genome. In 1995, Venter, Hamilton Smith, and colleagues at The Institute for Genomic Research (TIGR) published the first complete genome of a free-living organism, the bacterium Haemophilus influenzae. The circular chromosome contains 1,830,137 bases and its publication in the journal Science marked the first published use of whole-genome shotgun sequencing, eliminating the need for initial mapping efforts. By 2003, the Human Genome Project's shotgun sequencing methods had been used to produce a draft sequence of the human genome; it had a 92% accuracy. In 2022, scientists successfully sequenced the last 8% of the human genome. The fully sequenced standard reference gene is called GRCh38.p14, and it contains 3.1 billion base pairs.
Sources: en.wikipedia.org
Part of the WADA submission to the appeal, which the CAS accepted in its verdict, was that Thymosin Beta-4 was the only form of Thymosin which would have had the soft tissue recovery effect that Dank had attributed to it – text messages from Dank had specifically described Thymosin as the cornerstone of the soft tissue recovery program. Two urine samples taken from Essendon players during 2012 were also found to contain elevated Thymosin Beta-4; the levels were not high enough to fail the drug test, but they added to the cable of evidence against the players. Significantly, the CAS also determined that the players were "significantly at fault", disqualifying them from any penalty reduction. This was considered a surprise, as press throughout the entire saga had opined that by having followed the direction of club officials, the players would be found to have had no significant fault or negligence, qualifying them for a 50% penalty reduction. Key to this finding was the revelation that none of the eighteen different players who had been drug tested on a total of thirty occasions during the program had declared the supplements injections on their doping control forms, and that some had withheld information from the club doctor on Dank's instruction – revelations which damaged the credibility of other evidence put forward by the players.
=== United States herbalism fraud === Over the years 2017–2021, the US Food and Drug Administration (FDA) issued warning letters to numerous herbalism companies for illegally marketing products under "conditions that cause them to be drugs under section 201(g)(1) of the Act [21 U.S.C. § 321(g)(1)], because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body" when no such evidence existed. During the COVID-19 pandemic, the FDA and US Federal Trade Commission issued warnings to several hundred American companies for promoting false claims that herbal products could prevent or treat COVID-19 disease.
Austin was contacted by Paul Heyman of Extreme Championship Wrestling (ECW), who had previously managed him in WCW. Heyman hired him to do promos and in-ring interviews as he had not adequately recovered from his injury, paying Austin $500 (equivalent to $1,056 in 2025) a night. Changing his nickname to "Superstar", Austin debuted in ECW at Gangstas Paradise on September 18, 1995. While in ECW, Austin used the platform to develop his future "Stone Cold" persona as well as a series of vignettes running down WCW in general and Bischoff in particular, most memorably in several promos that mocked his then-status as Nitro host by introducing Monday NyQuil, where he was joined by "Bongo" (a set of drums, meant to represent Steve "Mongo" McMichael) in promoting the show "where the big boys play with each other." Several wrestlers have credited ECW as the place where Austin developed his microphone skills. Austin has credited Heyman as the man who taught him how to cut a promo. Whipwreck, who was the ECW World Heavyweight Champion at the time, defeated Austin in an upset to retain the championship at November to Remember on November 18. At December to Dismember on December 9, Whipwreck defended the title against Austin and The Sandman in a three way dance. Austin eliminated Whipwreck from the match by pinning him following a Stun Gun, but was pinned himself after The Sandman punched him using brass knuckles.
=== Concrete exposed to hydrocarbon fires === Concrete cannot, by itself, withstand severe hydrocarbon fires. In the Channel Tunnel that connects the United Kingdom and France, an intense fire broke out and reduced the concrete lining in the undersea tunnel down to about 50 mm. In ordinary building fires, concrete typically achieves excellent fire-resistance ratings, unless it is too wet, which can cause it to crack and explode. For unprotected concrete, the sudden endothermic reaction of the hydrates and unbound humidity inside the concrete generates pressure high enough to spall off the concrete, which falls in small pieces on the floor of the tunnel. Humidity probes are inserted into all concrete slabs that undergo fire testing to test for this, even for the less severe building elements curve (DIN4102, ASTM E119, BS476, or ULC-S101). The need for fireproofing was demonstrated, among other fire protection measures, in the European "Eureka" Fire Tunnel Research Project, which gave rise to building codes for the trade to avoid the effects of such fires upon traffic tunnels. Cementitious spray fireproofing must be certification-listed and applied in the field as per that listing, using a hydrocarbon fire test curve such as the one used in UL1709.
Sources: en.wikipedia.org
Arrived in Europe in the 16th century, this solanaceous plant (with a pink skinned tuber in England and a yellow skin in Spain) spread in the Principality of Liege, Ireland, Flanders, Germany, Switzerland, Italy, Austria, etc. In France, its resemblance with toxic species (for example the daturas, known for their toxicity to livestock, but also to humans) and the lack of techniques of conservation and use, are brakes to its cultivation, beside purely agronomic reasons (bad ecological adaptation) or religious (non-perception of the tithe on this food). In the Théâtre d'agriculture et Mesnage des champs, published in 1600, Olivier de Serres already recommended the cultivation of the "white truffle" or "cartoufle" and found it to have a flavor worthy of the best black truffles. Around 1750, the cultivation and consumption of tubers were recommended by several people or institutions: Duhamel du Monceau, the bishops of Albi and Léon, the minister Turgot, Rose Bertin, the Agricultural Society of Rennes. Ten years before the publications of Antoine Parmentier and Samuel Engel, Duhamel du Monceau "strongly exhorts farmers not to neglect the cultivation of this plant" and remarks that "it is an excellent food especially with a little bacon and salted pork". But the French population remains more than reticent before this dish: the majority of French people still disdain it as a food for humans, even if it is cultivated and used in some regions.
==== Early career (1980–1981) ==== After leaving the Army, Marrow wanted to stay away from gang life and violence and instead make a name for himself as a DJ. As a tribute to Iceberg Slim, Marrow adopted the stage name Ice-T. While performing as a DJ at parties, he received more attention for his rapping, which led Ice-T to pursue a career as a rapper. However, he soon returned to a life of crime and robbed jewelry stores with his high school friends. Ice-T's raps later described how he and his friends pretended to be customers to gain access before smashing the display glass with small sledgehammers. Ice-T's friends Al P. and Sean E. Sean went to prison. Al P. was caught in 1982 and sent to prison for robbing a high-end jewelry store in Laguna Niguel for $2.5 million in jewelry. Sean was arrested for possession of not only cannabis, which Sean sold, but also material stolen by Ice-T. Sean took the blame and served two years in prison. Ice-T stated that he owed a debt of gratitude to Sean because his prison time allowed him to pursue a career as a rapper. Concurrently, he wound up in a car accident and was hospitalized as a John Doe because he did not carry any form of identification due to his criminal activities. After being discharged from the hospital, he decided to abandon the criminal lifestyle and pursue a professional career rapping. Two weeks after being released from the hospital, he won an open mic competition judged by Kurtis Blow at the Carolina West nightclub.
==== Inflammation ==== When particular GPCRs are activated by their specific chemokines Gβγ directly activates PI3Kγ which is involved in the recruitment of neutrophils that contribute to inflammation. It has been discovered that the inhibition of PI3Kγ significantly reduces inflammation. PI3Kγ is the intended target molecule in the prevention of inflammation as it is the common signalling effector of many different chemokine and receptor types involved in promoting inflammation. Although PI3Kγ is the intended target there are other isoforms of PI3 which perform different functions from PI3Kγ. Since PI3Kγ is specifically regulated by Gβγ, while other isoforms of PI3 are largely regulated by other molecules, inhibiting Gβγ signalling would provide the desired specificity of a therapeutic agent designed to treat inflammation.
Sources: en.wikipedia.org
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.
United States approval for type 2 diabetes was granted in 2022, and a chronic weight management indication was added later. Approval timelines differ across other jurisdictions. Earlier human data came from phase 1 and phase 2 trials published before those decisions.
Native hormones are short-lived peptides that enzymes degrade within minutes. Tirzepatide carries non-natural residues and a fatty acid chain that resist this breakdown and extend circulation time. The result is a longer interval between administrations than the natural hormones could support.
It separates molecules by hydrophobicity, which is effective for distinguishing an intact peptide from truncated or chemically modified forms. A C18 column with an acidic water-organic mobile phase is a standard configuration.